Baillie Gifford & CO Penumbra Inc Transaction History
Baillie Gifford & CO
- $128 Billion
- Q2 2025
A detailed history of Baillie Gifford & CO transactions in Penumbra Inc stock. As of the latest transaction made, Baillie Gifford & CO holds 922,127 shares of PEN stock, worth $236 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
922,127
Previous 688,995
33.84%
Holding current value
$236 Million
Previous $184 Million
28.44%
% of portfolio
0.19%
Previous 0.17%
Shares
32 transactions
Others Institutions Holding PEN
# of Institutions
506Shares Held
30MCall Options Held
266KPut Options Held
59.2K-
Black Rock Inc. New York, NY4.26MShares$1.09 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.86MShares$989 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.37MShares$352 Million0.04% of portfolio
-
State Street Corp Boston, MA1.17MShares$300 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY864KShares$221 Million3.4% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $9.7B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...